Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their…
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and…
During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no…
A new study from the University of Wisconsin-Madison suggests that chemotherapy may not be reaching its full potential, in part…